rs9819506 — GHSR GHSR Promoter Variant (Ghrelin Receptor Signaling)

The GHSR Promoter Tag Variant That Tracks Appetite-Driven Weight Gain

Ghrelin is the body's primary hunger hormone — a gut-derived peptide that rises before meals, falls after eating, and drives appetite through the growth hormone secretagogue receptor (GHSR-1a)¹¹ growth hormone secretagogue receptor (GHSR-1a)
The only known peripherally-derived orexigenic receptor; signals through both hypothalamic homeostatic circuits and mesolimbic reward pathways. The amount of GHSR protein expressed in appetite-regulating brain regions determines how powerfully ghrelin can drive eating behavior. rs9819506 sits approximately 5 kb upstream of rs490683 in the GHSR promoter haplotype block²² GHSR promoter haplotype block
A cluster of SNPs in the 5′-regulatory region of GHSR that tend to be inherited together; variants in this block collectively influence GHSR transcription levels. It has been associated with body weight and weight loss response in two independent cohorts, though the mechanistic basis appears to lie in linkage disequilibrium with nearby functional variants rather than in a direct promoter effect of its own.

The Mechanism

Unlike rs490683 — the characterized functional SNP in the same region, where the G allele preserves a nuclear factor 1 (NF-1) transcription factor binding site and elevates GHSR expression — rs9819506 has not been found to alter protein binding in gel-shift (EMSA) experiments³³ gel-shift (EMSA) experiments
Electrophoretic mobility shift assay: a technique that detects whether specific nuclear proteins bind to a DNA sequence by observing a "shift" in band migration on a gel. The Mager 2008 analysis found no differential binding between the C and T alleles of rs9819506, despite the clear association with body weight. This pattern — phenotypic association without local functional evidence — is characteristic of a tag SNP: rs9819506 likely tracks a nearby functional variant through LD rather than disrupting a regulatory element itself. Its position in the same promoter haplotype block as the NF-1 site variant rs490683 supports this interpretation. Individuals carrying the C allele (the more common allele globally, ~68%) tend toward higher GHSR expression-associated phenotypes; T allele carriers track toward lower ghrelin signaling capacity.

The Evidence

The foundational study from Mager et al. 2008⁴⁴ Mager et al. 2008
PLoS One; Finnish Diabetes Prevention Study cohort; N=507 overweight adults with impaired glucose tolerance followed 3 years during an intensive lifestyle intervention genotyped 7 GHSR SNPs and found rs9819506 associated with body weight at 3-year follow-up (p=0.036). Individuals homozygous for the A allele (coding-strand notation; equivalent to plus-strand TT) showed the lowest body weight across the study period, with a direct pairwise comparison between GG and AA genotypes reaching p=0.030. Importantly, this was a weight-tracking association rather than a weight-loss-response finding — rs490683, not rs9819506, showed the clearest dietary intervention response in that dataset.

The Matzko et al. 2012 RYGB cohort⁵⁵ Matzko et al. 2012 RYGB cohort
Geisinger Health System; N>650 patients undergoing Roux-en-Y gastric bypass; genotyped for rs9819506 and rs490683; 30-month post-surgical weight loss trajectories found that rs9819506 was independently associated with post-surgical weight loss in an additive model (p<0.0001). The minor T allele was associated with more weight loss; CC homozygotes lost slightly less weight over 30 months. The effect was also significant under a dominant model for T allele carriage (p=0.0072). This replicated the directionality of the Mager 2008 finding: T allele = lower body weight / better weight loss response. A 2023 systematic review⁶⁶ 2023 systematic review
Duarte et al., Current Obesity Reports; reviewed SNPs associated with body weight trajectory after bariatric surgery confirmed rs9819506 among variants predictive of higher post-surgical weight loss.

Practical Actions

CC homozygotes (the most common genotype at ~42% globally) carry the allele associated with higher baseline body weight and slightly attenuated weight loss responses across both lifestyle and surgical interventions. The mechanism is likely indirect — through LD with GHSR promoter variants that maintain elevated ghrelin receptor expression — meaning that ghrelin's appetite drive may be somewhat stronger at baseline. Dietary strategies that target ghrelin suppression (particularly high-protein meals, which produce the strongest acute ghrelin suppression of all macronutrients) are the most genotype-relevant lever available. CT heterozygotes carry one T allele and occupy an intermediate position. TT individuals show the most favourable association with weight outcomes.

Interactions

rs9819506 sits in the same GHSR promoter haplotype block as rs490683 (already on the platform) and rs2922126. Because rs9819506 is likely a tag SNP rather than a functional variant, individuals carrying both rs9819506-CC and rs490683-GG may experience compounding ghrelin receptor expression effects — though the degree of independent contribution from rs9819506 beyond what rs490683 already captures depends on the LD structure between the two. rs696217 (GHRL Leu72Met) affects postprandial ghrelin ligand suppression; combined disruption of both the ligand level (rs696217) and receptor signaling (this locus and rs490683) could produce additive appetite dysregulation.